Rypraz-IT Capsules provide a premium, clinically integrated combination therapy meticulously designed for the treatment of gastroesophageal reflux disease (GERD), hyperacidity, and non-ulcer functional dyspepsia. By uniting a high-efficiency proton pump inhibitor (PPI) with a targeted prokinetic agent, this formulation successfully addresses both the chemical and mechanical triggers of acid reflux where single antacid therapies fall short.
The first active component, Rabeprazole Sodium (20 mg), operates as a potent proton pump inhibitor. It targets the gastric parietal cells, selectively blocking the $H^+/K^+\text{-ATPase}$ enzyme system (the acid pump) to shut down the final stage of stomach acid secretion. This enteric-coated (E.C) formulation ensures that the rabeprazole safely bypasses harsh stomach fluids to dissolve efficiently in the intestines for maximum bioavailability. The second component, Itopride Hydrochloride (150 mg), is a specialized prokinetic agent with dual mechanical actions. It increases acetylcholine release by antagonizing dopamine $D_2$ receptors and simultaneously inhibits acetylcholinesterase breakdown. This sustained-release (SR) action strengthens lower esophageal sphincter tone, enhances gastric coordination, and accelerates stomach emptying. Together, Rypraz-IT stops acid from flowing upward and keeps digestion moving downward smoothly.
Key Benefits
-
Dual Mechanism Reflux Relief: Shuts down excessive stomach acid while physically prompting food to move through the digestive tract correctly.
-
Sustained Prokinetic Action: The 150 mg sustained-release itopride pellets work steadily throughout the day to completely eliminate heavy post-meal bloating and nausea.
-
Rapid Gastro Protection: Gastric-shielded rabeprazole granules facilitate quick tissue healing across irritated esophageal structures.
-
Eliminates Sour Burps: Improves mechanical swallowing valves to keep digestive juices firmly inside the stomach chamber.
-
Trusted Quality: Formulated under the high-standard manufacturing parameters of Arlak Biotech, ensuring exact structural release profiles.
Directions for Use
-
Take exactly as directed by your gastroenterologist or physician.
-
Rypraz-IT must be taken on an empty stomach, preferably first thing in the morning, at least 30 to 60 minutes before breakfast. Taking it with food significantly lowers the clinical performance of the active ingredients.
-
Swallow the capsule whole with a full glass of water. Do not open, crush, chew, or break the capsule or its inner pellets, as doing so will ruin the protective enteric-coated and sustained-release matrix frameworks.
Safety & Precautions
-
Do not modify your dose or stop taking this medication suddenly without professional feedback, as structural acid rebound states can occur.
-
Inform your specialist if you have an underlying history of severe liver impairment, osteoporosis, or vitamin B12 deficiencies prior to launching extended treatment timelines.
-
Contraindicated for individuals where increased gastrointestinal motility could be harmful (such as active gastrointestinal bleeding, mechanical obstructions, or bowel perforations).
-
Long-term use of proton pump inhibitors may occasionally be linked to minor bone thickness adjustments; ensure adequate vitamin D and calcium tracking if requested by an expert.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat, and environmental room moisture.
-
Keep the capsules safely stored inside their original protective blister configuration until the time of consumption.
